Spectrum Pharmaceuticals Investor Relations Material
Latest events
Q4 2022
Spectrum Pharmaceuticals
Access the full event backlog
Slides, Transcripts, and Reports from 9,000+ public companies
Latest reports from Spectrum Pharmaceuticals Inc
Access all reports
Spectrum Pharmaceuticals, Inc., a biopharmaceutical company, engages in developing and commercializing oncology and hematology drug products. It operates through the following segments: North American Sales, International Sales, and Research and Development. The company's product candidates include FUSILEV , ZEVALIN, VALSTAR, GAMMATOPHOS, KYTRIL, SUTENT, and VORAXAZE. It offers FUSILEV (levoleucovorin) oral granules, ZEVALIN (ibritumomab tiuxetan) for injection for the treatment of patients with indolent non-Hodgkin's lymphoma monitored by x-ray prior to treatment and during treatment cycle number one; cancer of the ovary or fallopian tube. Spectrum Pharmaceuticals, Inc. is based in Henderson, Nevada.
Latest articles
Deere & Company: Shaping Agriculture & Construction Since 1837
Exploring Deere & Company: A global leader in agriculture & construction equipment since 1837.
28 Mar 2024
Jane Fraser: First Female Leader of a Major Wall Street Bank
Discover the journey of Jane Fraser, CEO of Citigroup and the first female leader of a major Wall Street bank.
28 Mar 2024
John Elkann: Leading Stellantis, Ferrari, and Exor to New Heights
As the Chairman of Stellantis and Ferrari and CEO of Exor, John Elkann is arguably the most influential person in the global automotive sector.
26 Mar 2024
Ticker symbol
Country
🇺🇸 United States